Hot News

【新股IPO】昭衍新藥6127截孖展已錄655億元、超額認購111倍(不斷更新) - 香港經濟日報- 即時新聞頻道- 即市財經- 新股IPO @ 2021-02-19T12: Back Hot News
Keyword:新股 昭衍新藥
Concept:投資頻道 , 昭衍新藥孖展認購
【新股IPO】昭衍新藥6127截孖展 已錄655億元、超額認購111倍(不斷更新)
新股IPO|昭衍新藥入場費15,252元 清池、奧博為基石投資者 A股三年半內升25倍
昨日不少認購新股資金暫時仍被諾輝健康凍結,因此昭衍新藥首日孖展反應普通。綜合本地4家券商數據,首日共借出102.62億元,該股公開發售集資額約5.89億元,僅計券商孖展,公開發售暫錄16倍超購。
【本報訊】牛年首只超購王新股諾輝健康(6606)今日首掛,昨晚暗盤一度升兩倍,收報69.3元,升159.9%,一手賬面賺21,320元。據本報統計顯示乙組投資者共23,587名食白果,以九成孖展入飛計,最多者或白蝕孖展息達13,851元。

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.